RecruitingPhase 3NCT05511363
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Canton, OH · +58 more sites
Alzheimer's Disease clinical trials in Canton, OH
1 recruiting alzheimer's disease studies with a site in Canton, OH.
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.